Biomed Central Ltd

SHERPA: Unknown

People

  1. O'Reilly
    O'Reilly
  2. Motzer
    Motzer
  3. Healey
    Healey
  4. Romesser
    Romesser
  5. Abou-Alfa
    Abou-Alfa
  6. Capanu
    Capanu
  7. Chou
    Chou
  8. Garcia Aguilar
    Garcia Aguilar
  9. Jungbluth
    Jungbluth
  10. La Quaglia
    La Quaglia

Groups

  1. Department of Medicine (30)
  2. Solid Tumor Oncology Division (25)
  3. Surgery (15)
  4. Survivorship Research (12)
  5. Center for Pancreatic Cancer Research (11)
  6. Epidemiology and Biostatistics (10)
  7. GSK Faculty (10)
  8. Gastrointestinal Oncology Service (9)
  9. Department of Pathology and Laboratory Medicine (8)
  10. Genitourinary Oncology Service (8)
Search Within
  1. "BMC Cancer"
Formats
  1. Journal Article (65)
Groups
  1. Department of Medicine (30)
  2. Solid Tumor Oncology Division (25)
  3. Surgery (15)
  4. Survivorship Research (12)
  5. Center for Pancreatic Cancer Research (11)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Eileen O'Reilly (6)
  2. Sara Olson (5)
  3. Robert Motzer (4)
  4. John Healey (3)
  5. Paul Romesser (3)
  6. Achim Jungbluth (2)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2022 (6)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. BMC Cancer (65)

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
    Journal Article

    McMillan, M. T.; Reyngold, M.; Crane, C. H.; O'Brien, D. A. R.; Williams, V. M.; Zinovoy, M.; Cuaron, J. J.; Gönen, M.; Kaiser, A.; Sopka, D. M.; more...
    BMC Cancer (2025)

    Fulltext@MSK | Save
  • Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
    Journal Article

    Alvarez, J. A.; Shi, Q.; Dasari, A.; Garcia-Aguilar, J.; Sanoff, H.; George, T. J.; Hong, T.; Yothers, G.; Philip, P.; Nelson, G.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)
    Journal Article

    Lara, P. N.; Villanueva, L.; Ibanez, C.; Erman, M.; Lee, J. L.; Heinrich, D.; Lipatov, O. N.; Gedye, C.; Gokmen, E.; Acevedo, A.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
    Journal Article

    Hitchcock, K. E.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; George, M.; Jee, K. W.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
    Journal Article

    Schöffski, P.; George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Serrano, C.; Jones, R. L.; Attia, S.; D’Amato, G.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Rationale and design of ON-TRK: A novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
    Journal Article

    Yang, J. C. H.; Brose, M. S.; Castro, G.; Kim, E. S.; Lassen, U. N.; Leyvraz, S.; Pappo, A.; López‐Ríos, F.; Reeves, J. A.; Fellous, M.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
    Journal Article

    El-Khoueiry, A. B.; Meyer, T.; Cheng, A. L.; Rimassa, L.; Sen, S.; Milwee, S.; Kelley, R. K.; Abou-Alfa, G. K.
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
    Journal Article

    ten Hoorn, S.; Waasdorp, C.; van Oijen, M. G. H.; Damhofer, H.; Trinh, A.; Zhao, L.; Smits, L. J. H.; Bootsma, S.; van Pelt, G. W.; Mesker, W. E.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Relationship between insurance status and interhospital transfers among cancer patients in the United States
    Journal Article

    Rubens, M.; Ramamoorthy, V.; Saxena, A.; Appunni, S.; Sundil, S.; Veledar, E.; McGranaghan, P.; Tonse, R.; Fitz, S. J. T.; Chuong, M. D.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: An open-label, multi-center phase I study
    Journal Article

    Schaff, L. R.; Lobbous, M.; Carlow, D.; Schofield, R.; Gavrilovic, I. T.; Miller, A. M.; Stone, J. B.; Piotrowski, A. F.; Sener, U.; Skakodub, A.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save